Data Composite

Atropine Sulfate Injection Shortage

17 of 19 tracked records currently active across 8 manufacturers.

Manufacturers report shortage status per product/package to the FDA independently, so the same generic drug can be short from one company while another still has supply -- the table below breaks that down company by company.

CompanyBrand nameStatusLast updated
Hospira, Inc., a Pfizer Company — To Be Discontinued 11/07/2025
Hospira, Inc., a Pfizer Company — To Be Discontinued 11/07/2025
Hospira, Inc., a Pfizer Company ATROPINE SULFATE Current 10/21/2026
Hospira, Inc., a Pfizer Company ATROPINE SULFATE Current 10/21/2026
Accord Healthcare Inc. ATROPINE SULFATE Current 10/17/2026
Accord Healthcare Inc. — Current 10/17/2026
Accord Healthcare Inc. ATROPINE SULFATE Current 10/17/2026
Accord Healthcare Inc. ATROPINE SULFATE Current 10/17/2026
Amphastar Pharmaceuticals, Inc. ATROPINE SULFATE Current 10/16/2026
American Regent, Inc. ATROPINE SULFATE Current 10/15/2026
American Regent, Inc. ATROPINE SULFATE Current 10/15/2026
Fresenius Kabi USA, LLC ATROPINE SULFATE Current 10/15/2026
Medefil, Inc. ATROPINE SULFATE Current 10/15/2026
Hikma Pharmaceuticals USA, Inc. ATROPINE SULFATE Current 10/14/2026
Accord Healthcare Inc. ATROPINE SULFATE Current 10/03/2026
Somerset Therapeutics, LLC ATROPINE SULFATE Current 09/11/2026
Somerset Therapeutics, LLC ATROPINE SULFATE Current 09/11/2026
Somerset Therapeutics, LLC ATROPINE SULFATE Current 09/11/2026
Accord Healthcare Inc. — Current 09/01/2026

← All shortages